Source:http://linkedlifedata.com/resource/pubmed/id/20043119
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-12-31
|
pubmed:abstractText |
Placenta growth factor (PLGF) is a member of the vascular endothelial growth factor (VEGF) family, a group of angiogenic growth factors. Recently, isoforms have been identified. This study examined PLGF-1, PGF-2 and its receptor neuropilin-1 levels in human breast cancer in relation to patient's clinical parameters and how changes in expression may be linked to prognosis of the disease. PLGF-1, PGF-2 and neuropilin-1 transcript expression and distribution were examined quantitatively using real-time quantitative polymerase chain reaction (Q-PCR) on a cohort of human breast cancer (n=114) and background breast tissue (n=30) with a 10-year follow-up. Protein expression was assessed by an immunohistochemical method. We demonstrate that PLGF-1 transcript levels were significantly elevated when comparing tumours from patients with poor outcome and patients who remained disease-free (P=0.03), indicating a potential prognostic value. Immunohistochemistry demonstrated a marked increased in PGF-2 expression in tumour section compared with normal tissues (P<0.05). PGF-2 transcripts, showed little change in expression between tumour and background. High levels of PLGF-1 and PGF-2 were seen in ERbeta-negative breast tumour tissues. Neuropilin transcript was below detection in substantial portion of the samples and was more frequently detected in high grade tumours (P=0.008 vs. low grade) and in tumours from patients who died of breast cancer (P<0.001 vs. those who remained disease-free). Our study shows that PLGF isoforms PLGF-1 and PGF-2 and indeed their receptor neuopilin, have an aberrant pattern of expression and that high levels of the PLGF-1 and neuropilin are linked to a poor prognosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Neuropilins,
http://linkedlifedata.com/resource/pubmed/chemical/Pregnancy Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/placenta growth factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1791-2431
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
537-44
|
pubmed:meshHeading |
pubmed-meshheading:20043119-Breast Neoplasms,
pubmed-meshheading:20043119-Cohort Studies,
pubmed-meshheading:20043119-Female,
pubmed-meshheading:20043119-Follow-Up Studies,
pubmed-meshheading:20043119-Humans,
pubmed-meshheading:20043119-Mammary Glands, Human,
pubmed-meshheading:20043119-Neuropilins,
pubmed-meshheading:20043119-Pregnancy Proteins,
pubmed-meshheading:20043119-Prognosis,
pubmed-meshheading:20043119-Protein Isoforms,
pubmed-meshheading:20043119-Receptors, Estrogen,
pubmed-meshheading:20043119-Survival Analysis
|
pubmed:year |
2010
|
pubmed:articleTitle |
PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance.
|
pubmed:affiliation |
Department of Surgery, Cardiff School of Medicine, Cardiff University, Cardiff, UK. escudero-esparzaa@cardiff.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|